Rankings
▼
Calendar
VIR Q2 2019 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
VIR
Vir Biotechnology, Inc.
$1B
Q2 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$86,000
-96.3% YoY
Gross Profit
-$30M
-34557.0% margin
Operating Income
-$36M
-41591.9% margin
Net Income
-$34M
-39451.2% margin
EPS (Diluted)
$-0.31
QoQ Revenue Growth
+405.9%
Cash Flow
Operating Cash Flow
-$24M
Free Cash Flow
-$27M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$457M
Total Liabilities
$55M
Stockholders' Equity
$401M
Cash & Equivalents
$81M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$86,000
$2M
-96.3%
Gross Profit
-$30M
-$21M
-42.4%
Operating Income
-$36M
-$28M
-28.9%
Net Income
-$34M
-$28M
-21.1%
← FY 2019
All Quarters
Q3 2019 →